Drugs / Recombinant human follicle stimulating hormone
Recombinant human follicle stimulating hormone
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT05266924 | Jul 2022 → Aug 2023 | female infertility | Bharat Serums and Vaccines Limited | Unknown | No outcome recorded |
| Phase 3 | NCT01071200 | Mar 2005 → Apr 2009 | — | Merck KGaA, Darmstadt, Germany | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00989781 | Sep 2009 → Sep 2013 | polycystic ovary syndrome | University of California, San Diego | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT01110707 Background | Jan 2005 → Nov 2006 | infertility disorder, ovarian disorder | Merck KGaA, Darmstadt, Germany | Completed | Missed primary |
| Phase 3 | NCT01084265 Background | Feb 2004 → Dec 2005 | hypogonadism | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2001-05-16 | Alkermes, Inc. | Alkermes and Serono to Proceed With Development of Long-acting Formulation of Recombinant Human Follicle Stimulating Hormone (R-hFSH) alkermes.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant human follicle stimulating hormone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00989781 ↗ |
| Known as | Gonal-F (r-hFSH) | “Gonal-F (r-hFSH)” NCT01084265 ↗ |
| Known as | r-hFSH | “recombinant human follicular stimulating hormone (r-hFSH) 300-450 International Units (IU)” NCT01110707 ↗2“The participant will receive r-hFSH, fixed-dose for 5 days” NCT05266924 ↗ “Recombinant human follicle-stimulating hormone (r-hFSH)” NCT01084265 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant human follicle stimulating hormone” NCT00989781 ↗ |
| Route | Intravenous | “Recombinant human follicle stimulating hormone will be given iv and blood samples obtained before and 24 hr later.” NCT00989781 ↗ |